Vimal Mehta, CEO and President at BioXcel Therapeutics, Inc. (BTAI), sold 6,500 shares at $25.79 ($168K) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Scheduled sale ($168k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |